Cantor Fitzgerald Analysts Lower Earnings Estimates for SPRY
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Equities researchers at Cantor Fitzgerald cut their FY2025 earnings per share (EPS) estimates for shares of ARS Pharmaceuticals in a research note issued to investors on Thursday, May 15th. Cantor Fitzgerald analyst J. Schimmer now forecasts that the company will post earnings of ($1.44) per share for […]
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Equities researchers at Cantor Fitzgerald cut their FY2025 earnings per share (EPS) estimates for shares of ARS Pharmaceuticals in a research note issued to investors on Thursday, May 15th. Cantor Fitzgerald analyst J. Schimmer now forecasts that the company will post earnings of ($1.44) per share for […]
